constrain

(redirected from constrainer)
Also found in: Dictionary, Thesaurus, Legal.

constrain (one) from (doing something)

To prevent or hinder one from doing something. For years, stage fright constrained me from singing in public.
See also: constrain

constrain someone from doing something

to prevent someone from doing something; to hold someone back from doing something. I hope this doesn't constrain you from trying out for the play. His handicap did not constrain him from finishing the race.
See also: constrain
References in periodicals archive ?
The view of the Audit Commission, as well as Hackney executives: The systems had become constrainers rather than enablers.
More important, symmetries are only defeasible constrainers of rational credence.
We surveyed 185 oncologists in the United States, France, and Germany, respondents were also questioned on many other topics which are pivotal to understanding the current and future uptake of biosimilars, including their concerns about biosimilars, drivers and constrainers of adoption, views on indication extrapolation, opinions on automatic substitution, attitudes towards reimbursement, and the clinical trial requirements for biosimilars.
Surveyed nephrologists and endocrinologists were also questioned on many other topics which are pivotal to understanding the current and future uptake of biosimilars, including their level of familiarity with biosimilars, concerns about biosimilars, drivers and constrainers of adoption, views on indication extrapolation, attitudes towards reimbursement, the expected impact of 'biobetters' and the clinical trial requirements for biosimilars.
Apart from opinions on automatic substitution, surveyed specialist physicians (n=549) were questioned on many other topics which are pivotal to understanding the current and future uptake of biosimilars, including their level of familiarity with biosimilars, concerns about biosimilars, drivers and constrainers of adoption, views on indication extrapolation, attitudes towards reimbursement, the expected impact of 'biobetters' and the clinical trial requirements for biosimilars.
Full browser ?